Globus Medical
GMEDGlobus Medical is a leading medical device company focused on developing and commercializing healthcare solutions for patients with musculoskeletal disorders.
Earnings
Next report
Nov 5, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Globus Medical is a leading medical device company focused on developing and commercializing healthcare solutions for patients with musculoskeletal disorders. The company leverages an engineering-driven product development engine to provide a comprehensive portfolio of spinal implants, orthopedic trauma solutions, and robotic surgical platforms. Its core value proposition centers on improving clinical outcomes and surgical efficiency through the integration of advanced hardware and enabling technologies.
Globus Medical is a major player in the spine and orthopedic markets, distinguished by its rapid product development cycle and the integration of robotic navigation with traditional implants.
FAQ
- What is Globus Medical's market cap?
- Globus Medical (GMED) has a market capitalization of $10.1B and trades on NYSE.
- What is Globus Medical's revenue and profitability?
- Globus Medical generated $3.1B in trailing twelve-month revenue with net income of $535.4M, representing a net margin of 17.0%. Gross margin stands at 68.5%, with free cash flow of $755.6M. The latest reported period is Q2 2026.
- Who are Globus Medical's competitors?
- Globus Medical's key competitors include Orthofix, Stryker, Alphatec Holdings, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Globus Medical have?
- Globus Medical's subsidiaries include NuVasive, Inc., Nevro Corp., Synoste Oy, and others.
- Where is Globus Medical headquartered?
- Globus Medical is headquartered in United States of America and employs approximately 5,000 people. It has been publicly traded since 2012.
